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Abstract: The carbazole compounds PK9320 (1-(9-ethyl-7-(furan-2-yl)-9H-carbazol-3-yl)-N- methyl-
methanamine) and PK9323 (1-(9-ethyl-7-(thiazol-4-yl)-9H-carbazol-3-yl)-N-methylmethanamine),
second-generation analogues of PK083 (1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine), restore
p53 signaling in Y220C p53-mutated cancer cells by binding to a mutation-induced surface crevice
and acting as molecular chaperones. In the present paper, these three molecules have been tested
for mutant p53-independent genotoxic and epigenomic effects on wild-type p53 MCF-7 breast ade-
nocarcinoma cells, employing a combination of Western blot for phospho-γH2AX histone, Comet
assay and methylation-sensitive arbitrarily primed PCR to analyze their intrinsic DNA damage-
inducing and DNA methylation-changing abilities. We demonstrate that small modifications in
the substitution patterns of carbazoles can have profound effects on their intrinsic genotoxic and
epigenetic properties, with PK9320 and PK9323 being eligible candidates as “anticancer compounds”
and “anticancer epi-compounds” and PK083 a “damage-corrective” compound on human breast
adenocarcinoma cells. Such different properties may be exploited for their use as anticancer agents
and chemical probes.
Keywords: genomic instability; carbazole derivatives; epigenetics; DNA methylation; breast cancer
1. Introduction
Genotoxicity, as defined by toxicological genetics and mutagenesis, describes the
ability of chemical agents to induce modifications to the DNA nucleotide sequence or
double helix structure of an organism, damaging its genetic information, thereby causing
mutations that can lead to the onset of cancer [1]. DNA damage is one of the most
dangerous threats to cellular homeostasis, and, for this reason, the cellular response to
this event is immediate and vigorous. This DNA-damage response (DDR) encompasses
numerous metabolic pathways, and its defects leave cells susceptible to genomic instability,
predispose to further genomic errors and, lastly, transformation.
Since the early discovery of the antibiotic properties of the carbazole alkaloids ellip-
ticine and murrayanine extracted from Ochrosia elliptica Labill and Murraya koenigii Spreng,
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respectively [2,3], natural carbazoles and their synthetic derivatives have been extensively
studied and incorporated as key structural motifs in a number of approved drugs acting
against a wide spectrum of diseases, including cancer, microbial infections and neurological
disorders [4–6]. However, carbazoles have also been shown to induce epigenetic anomalies,
such as changes in DNA methylation status, and also to exert genotoxic effects. To cite
some examples, exposure to mahanine, a carbazole alkaloid from Micromelum minutum,
was found to be responsible for the negative modulation of the cellular levels of selected
DNA methyltransferases in prostate tumor cells, thereby restoring the expression of the
epigenetically silenced tumor suppressor gene RASSF1A (Ras Association Domain Family
Member 1). Moreover, SH-I-14 was shown to determine the promoter demethylation-
induced reactivation of tumor-suppressor gene expression in triple-negative breast cancer
cells. The epigenetic impact of 2,7-dibromocarbazole and 6-formylindolo [3,2-b]carbazole
has been also acknowledged. In particular, the former molecule was proven to demethylate
Ang2 (angiopoietin 2) gene promoter and potentiate its expression, resulting in deficient
angiogenesis by endothelial cells. The latter one, a ligand of the aryl hydrocarbon receptor,
was found to repress the expression of the CYP1A1 (aryl hydrocarbon hydroxylase) gene in
hepatoma cells by targeting DNA methyltransferase 3A, which led to impairment of the
cellular detoxification system [7–10]. Furthermore, Valovičová et al. [11] demonstrated the
occurrence of significant levels of DNA strand breaks, micronuclei, and DNA adducts after
exposure of human keratinocytes to 7H-dibenzo[c,g]carbazole, and Zhanataev et al. [12]
reported genotoxic effects of two carbazole-derived xenomycins, PLX01107 and PLX01008,
initially developed as potential antifungal agents. Although the genotoxic and epigenotoxic
side effects of carbazoles can be an issue when administered to healthy tissues, thus limiting
the use of the compounds in clinical practice, these properties make them promising “anti-
cancer (epi)drugs” efficacious as preventative and/or treatment agents in a combinatorial
molecular therapy against metastatic cancer histotypes.
Carbazole derivatives have also been used as chemical chaperones to reactivate a
thermolabile p53 cancer mutant. The p53 cancer hotspot mutation Y220C greatly destabi-
lizes the p53 DNA-binding domain, which unfolds and aggregates at body temperature,
resulting in the loss of p53 tumor suppressor function [13]. Structural studies have further
shown that the mutation creates a druggable cavity on the surface that can be targeted by
small molecules. PK083 (Figure 1) is a carbazole-based small molecule selected as a starting
scaffold to stabilize and reactivate the Y220C mutant [14]. Structure-guided design then led
to second-generation analogues, including PK9320 and PK9323, which bound the mutant
with higher affinity and were more potent in stabilizing and reactivating the mutant than
the parent compound (Figure 1). Importantly, those second-generation carbazoles restored
p53 signaling in the liver cancer cell line HUH-7 bearing a homozygous Y220C mutation,
with potential future application in personalized cancer therapy [15,16].
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Figure 1. Chemical structures of the carbazole derivatives PK083, PK9320 and PK9323. 
Here, we were interested in gaining insights into potential mutant p53-independent 
genotoxic or epigenetic effects of this carbazole series at high compound concentrations, 
using compounds PK083, PK9320 and PK9323 as examples. We have therefore employed 
i r . i l t t res f t e carbazole erivatives P 083, P 9320 and P 9323.
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a combination of Western blot, Comet assay and methylation-sensitive arbitrarily primed
PCR techniques to analyze their DNA damage-inducing and DNA methylation-changing
abilities in wild-type p53 MCF-7 breast adenocarcinoma cells.
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2. Results
In order to elucidate the potential genotoxic mechanism exhibited by PK083, PK9320
and PK9323, histone H2AX phosphorylation and Comet assays were conducted after
exposure of MCF-7 breast cancer cells to each of the molecules. It is known that, in
response to ionizing radiation or DNA-damaging chemotherapeutic agents, DNA double-
strand breaks (DSB) are generated that rapidly result in the phosphorylation of the histone
H2A variant H2AX [17]. Because the phosphorylation of H2AX at Ser139 (γ-H2AX) is
abundant, fast and correlates with DSB, it represents a very sensitive marker of DNA
damage and the subsequent repair, and is therefore a commonly used test to identify
genotoxic compounds [18].
As shown in Figure 2, PK9323, at 10 µM concentration, led to enhanced γH2AX phos-
phorylation compared with the untreated control, correlating with more extensive DNA
damage. In contrast, PK083 and PK9320 were not found to affect the level of histone phos-
phorylation and were genotoxically inactive in that aspect. However, PK9320 showed a
cytotoxic effect, as evidenced by the drastic decrease in tubulin levels, suggesting cell death
or inhibition of cell growth. The exposure–response relationship was further investigated,
identifying PK9323 as relatively highly genotoxic, with an EC50 of 2.2 µM, which exceeds
that of cisplatin (EC50 = 4 µM), as shown in Figure 3. The optical densities of the Western
blot bands shown in both figures can be found in Figure S1.
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Figure 2. CF-7 cells ere treated ith D SO control or an indicated concentration of co pound.
After 20 h, cells were harvested, lysed and probed for DNA damage by Western blot analysis using a
phosphorylated γH2AX antibody. Western blot analysis of tubulin was used as a loading and cell
viability control.
To gain more insight into this latter aspect, MCF-7 cells were exposed to PK9323, and
its effect on cell morphology and growth rate was analyzed by microscopic observations
and direct cell counting also comparing it to those exerted by PK083 and PK9320. No sig-
nificant morphological change indicative of cell suffering or death could be observed with
all treatments, even when exposing cells to the maximum concentration of the compounds
(Figure S2).
The numbers of control and treated cells were then evaluated by counting in a haemo-
cytometer, and the results confirm that cell exposure to 10 µM PK9320 appeared to drasti-
cally decrease the cell count to circa 20% vs. control. Interestingly, also in the presence of
PK083 and PK9323 at 10 µM concentrations, the amount of cells decreased, although to
a less r degree than with PK9320 (ca. 39% and 40% vs. control, respectively). At a lower
concentration of 2.2 µM, PK9320 and PK9323 exerted only a n gligible ffect on ce l growth
(ca. 119% and 112% vs. control, respectively), whereas, conversely, PK083 induced an
average 76% increase in the cell number with respect to the untreated samples (Figure 4).
Int. J. Mol. Sci. 2021, 22, 3410 4 of 14
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Figure . F-7 cells were treated with 2-fold serial diluti ns of PK9323 from 10 down to 0 µM.
After 20 h, cells ere harvested, lysed and probed for DNA damage by Western blot analysis (A)
using a phosphorylated γH2AX antibody. Western blot analysis of tubulin was used as a loading and
cell viability control. B) Dose-response curve for γH2AX phosphorylation after treatment of MCF-7
cells with PK9323 for 20 h; DMSO was used as a no compound control. The EC50 of PK9323 is 2.2 ±
0.3 µM and cisplatin was tested in parallel at 4 µM as a reference DNA lesion-inducing drug. The
error bars correspond to the SD of three independent measurements.
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 4 of 15 
 
 
and cell viability control. B) Dose-response curve for γH2AX phosphorylation after treatment of 
MCF-7 cells with PK9323 for 20 h; DMSO was used as a no compound control. The EC50 of PK9323 
is 2.2 ± 0.3 μM and cisplatin was tested in parallel at 4 μM as a reference DNA lesion-inducing 
drug. The error bars correspond to the SD of three independent measurements. 
To gain more insight into this latter aspect, MCF-7 cells were exposed to PK9323, and 
its effect on cell morphology and growth rate was analyzed by microscopic observations 
and direct cell counting also comparing it to those exerted by PK083 and PK9320. No sig-
nificant morphological change indicative of cell suffering or death could be observed with 
all treatments, even when exposing cells to the maximum concentration of the compounds 
(Figure S2). 
The numbers of control and treated cells were then evaluated by counting in a hae-
mocytometer, and the results confirm that cell exposure to 10 μM PK9320 appeared to 
drastically decrease the cell count to circa 20% vs. control. Interestingly, also in the pres-
ence of PK083 and PK9323 at 10 μM concentrations, the amount of cells decreased, alt-
hough to a lesser d gree than with PK9320 (ca. 39% and 40% vs. control, espectivel ). At 
a lower concentration of 2.2 μM, PK9320 and PK9323 exerted only a negligible effect o  
cell growth (ca. 119% and 112% vs. control, respectively), whereas, conversely, PK083 in-
duced an average 76% increase in the cell number with respect to the untreated samples 
(Figure 4). 
 
Figure 4. Effect of the carbazole derivatives on the number of MCF-7 cells after 20 h of exposure. 
Cell numbers were measured by direct counting in a Bürker chamber after trypsinization. Error 
bars correspond to the SEM of three independent measurements. The black line represents the IQR 
values. * = p < 0.05 vs. control; ** = p << 0.001 vs. control. 
The possible occurrence of genomic DNA lesions induced by the carbazole com-
pounds was quantitatively evaluated by Comet assay in terms of average Olive Tail Mo-
ment (OTM), indicative of persistent single- and double-strand breaks. Preliminary data 
showed that the Student′s t test did not reveal significant differences between the OTM 
values obtained from the untreated and the control DMSO-vehicle-only exposed cultures 
(data not shown), thereby ensuring that the vehicle did not influence the experimental 
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the DMSO control, confirming that no toxic effect was exerted by the methylation inhibi-
tor on the cells under the conditions used. This suggested a very low probability of the 
onset of clonal selection, an important premise for the validation of the subsequent meth-
ylation analyses. Moreover, PK9320 and PK083, at both concentrations tested, appeared 
unable to cause damage to the genomic DNA, with PK083 rather exerting a protective 
Figure 4. Effect of the carbazole derivatives on the number of MCF-7 cells after 20 h of exposure.
Cell numbers were measured by direct counti g in a Bürker chamber after trypsinization. Error bars
correspond to the SEM of three independent measurements. The black line represents the I values.
* = p < 0.05 vs. control; ** = p << 0.001 vs. control.
The possible occurrence of genomic DNA lesions i ce by t e carbazole compounds
was quantitatively evaluated by Comet assay in terms of average live Tail Moment
(OTM), indicative of persistent single- and double-strand breaks. Preliminary data showed
that the Student′s t test did not reveal significant differences between the OTM values
obtained from the untreated and the control DMSO-vehicle-only exposed cultures (data
not shown), thereby ensuring that the vehicle did not influence the experimental data. The
data shown in Figure 5 indicate that the OTM of the DNA methyltransferase inhibitor
5-azacitidine (5-azaC)-treated cells was not significantly different from that of the DMSO
control, confirming that no toxic effect was exerted by the methylation inhibitor on the cells
under the conditions used. This suggested a very low probability of the onset of clonal
selection, an important premise for the validation of the subsequent methylation analyses.
Moreover, PK9320 and PK083, at both concentrations tested, appeared unable to cause
damage to the genomic DNA, with PK083 rather exerting a protective action, as shown by
the OTM value significantly lower than that of untreated cells. Conversely, as expected from
the results of the histone γH2AX phosphorylation assay, PK9323 induced a considerable
degree of genomic DNA damage at 2.2 µM concentration, whereas at 10 µM concentration
the difference with the DMSO control was not statistically significant, probably due to a
clonal selection phenomenon leading to the preferential survival of one or more clones
better equipped to repair DNA breakages.
Int. J. Mol. Sci. 2021, 22, 3410 5 of 14
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 5 of 15 
 
 
action, as shown by the OTM value significantly lower than that of untreated cells. Con-
versely, as expected from the results of the histone γH2AX phosphorylation assay, 
PK9323 induced a considerable degree of genomic DNA damage at 2.2 μM concentration, 
whereas at 10 μM concentration the difference with the DMSO control was not statistically 
significant, probably due to a clonal selection phenomenon leading to the preferential sur-
vival of one or more clones better equipped to repair DNA breakages. 
 
Figure 5. Effect of the carbazole derivatives on the occurrence of genomic DNA lesions in MCF-7 
cells after 20 h of exposure. (A) Representative micrographs of comet images obtained from MCF-7 
cells exposed to DMSO vehicle as control (a), 10 μM 5-azaC (b) and PK083 (c,d), PK9320 (e,f), or 
PK9323 (g,h) at 2.2 μM (c,e,g) or 10 μM concentrations (d,f,h), stained with Gel Red DNA Dye and 
observed with a Nikon Microphot SA fluorescence microscope. Each spot corresponds to the DNA 
of an individual cell: when round it represents the intact DNA which is a large macromolecule 
that poorly migrates in the electrophoretic field, when “comet shaped” it is symptomatic of DNA 
breaks rendering the molecule small enough to move in the gel. Microscopic magnification = 400×. 
(B) Histogram showing the induced genomic DNA damage evaluated as OTM by Comet assay. 
OTM is the product of the percentage of total DNA in the tail and the distance between the bulk of 
head and tail regions. The number of scored cells was 50 for each experimental condition. The 
black line represents the IQR values. * = p < 0.05 vs. control; ** = p << 0.001 vs. control. 
In a last set of assays, we investigated in more detail the epigenetic modulation car-
ried out by the three compounds through the analysis of the global methylation status of 
the genomic DNA. For this purpose, MeSAP-PCR experiments were carried out on single- 
(SDD) and double-digested DNA (DDD) samples obtained from control and PK083-, 
PK9320- or PK9323-treated MCF-7 cells at 2.2 and 10 μM concentrations. The DNA fin-
gerprintings were analyzed by densitometric scanning, and the numbers of variations, in 
terms of appearing/disappearing (A/D) and attenuation/intensification (A/I) of the band 
patterns in the SDD vs. DDD preparations, were determined (Figure 6). The obtained data 
are summarized in Table S1 and shown in the histogram in Figure 7 and indicated that 20 
h treatments with both concentrations of PK9320 and PK9323 were effective in modifying 
the global methylation pattern of cancer cell DNA, as shown by the different number, 
intensity and size of the bands in the matched control and exposed samples; in particular, 
the most numerous changes were observed after cell exposure to 2.2 μM PK9323. Con-
versely, the difference between the modulatory activities of PK083 and the vehicle alone 
was not significant. 
As expected, the results obtained with 5-azaC-treated cells were significantly differ-
ent from those of the control. This finding, in the absence of clonal selection towards an 
epigenetically unbalanced cell population, demonstrates that MCF-7 cells are sensitive to 
the modulation of DNA methylation mediated by the “DNA methyltransferase-S adeno-
sylmethionine (DNMT-SAM)” system, the main pathway by which genomic DNA meth-
ylation is ensured. 
Figure 5. Effect of the carbazole derivatives on the occurrence of genomic DNA lesions in MCF-7
cells after 20 h of exposure. (A) Representative micrographs of comet images obtained from MCF-7
e ls exposed to DMSO v hicle as control (a), 10 µM 5-azaC (b) an 083 (c,d), PK9320 (e,f), or
PK9323 (g,h) at 2.2 µM (c,e,g) or 10 µM concentrations (d,f,h), stained with Gel Red DNA Dye and
observed with a Nikon Microphot SA fluorescence microscope. Each spot corresponds to the DNA
of an individual cell: when round it represents the intact DNA which is a large macromolecule that
poorly mig ates in the electrophoretic field, whe “comet shaped” it is symptomatic of DNA breaks
rendering the molecule small enough to move in the gel. Microscopic magnification = 400× g. (B)
Histogram showing the induced genomic DNA damage evaluated as OTM by Comet assay. OTM
is the product of the percentage of total DNA i the tail and the distance between the bulk of head
and tail regions. The number of scored cells was 50 for each experimental condition. The black line
represents the IQR values. * = p < 0.05 vs. control; ** = p << 0.001 vs. control.
In a last set of assays, we investigated in more detail the epigenetic modulation carried
out by the three compounds through the analysis of the global methylation status of the ge-
nomic DNA. For this purpose, MeSAP-PCR experiments were carried out on single- (SDD)
and double-digested DNA (DDD) samples obtained from control and PK083-, PK9320- or
PK9323-treated MCF-7 cells at 2.2 and 10 µM concentrations. The DNA fingerprintings
were analyzed by densitometric scanning, and the numbers of variations, in terms of
appearing/disappeari g (A/D) and attenuation/intensification (A/I) of the band patterns
in the SDD vs. DDD pr parations, were determined (Figure 6). The obtained data are
summarized in Table S1 and shown in the histogram in Figure 7 and indicated that 20 h
treatments with both concentrations of PK9320 and PK9323 were effective in modifying
the global methylation pattern of cancer cell DNA, as shown by the different number,
intensity and size of the bands in the matched control and exposed samples; in particular,
the most numerous changes were observed after cell exposure to 2.2 µM PK9323. Con-
versely, the difference between the modulatory activities of PK083 and the vehicle alone
was not significant.
As exp cted, the results obtained with 5-azaC-treated cells w re significantly different from
those of the control. This finding, in the absence of clonal selection towards an epigenetically
unbalanced cell population, demonstrates that MCF-7 cells are sensitive to the modulation
of DNA methylation mediated by the “DNA methyltransferase-S adenosylmethionine
(DNMT-SAM)” system, the main pathway by which genomic DNA methylation is ensured.
All three carbazoles in this study have been investigated in pharmacokinetic (PK) studies,
notably looking at cytotoxicity in HepG2 liver cancer cells. Further studies looked at aque-
ous solubility and all compounds had acceptable values at pH 7 of >100 mM. Measurement
of clearance (compound metabolic stability), in mouse microsomes, showed PK9323 to
have a reasonable half-life (>1 h), coupled with a relatively low clearance with around 3%
unbound drug in plasma protein binding studies (PPB). PK9320 had the shortest half-life
and highest clearance of the three compounds studied; moreover, it had a very low %
PPB. Concerning compound cytotoxicity, the following results were obtained: PK083 (23
µM); PK9320 (4.8 µM); PK9323 (1.1 µM), with PK083 showing mild and PK9323 high
cytotoxicity in this assay (Table S2). These data appear to align well with the other studies
outlined above.
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3. Discussion
It is widely acknowledged that members of the family of carbazole-based molecules,
either natural or synthetic, represent promising compounds with the ability to act as
DNA intercalating agents and to interfere with the activity of crucial enzymes, such
as topoisomerases and telomerases [19]. The topology of DNA and the maintenance
of telomere length are two crucial endpoints whereby cells, physiologically, especially
transformed ones, make nicks in the DNA and manage them, thus exposing themselves
to the risk of creating free DNA ends prone to produce chromosomal aberrations that can
initiate/promote tumorigenesis or induce cell death [20,21].
reover, some carbazole-derived molecules affect DNA methylation at specific CpG
island [9]. Because of this property, the currently repres nt the mainst y of treatm nt
decisions for leukemia patients who are not suitable for intensive ch motherapy [22], also
because th y can b safely metabolized by CYP enzymes [23]. It is also importan to
rem ber that the expression of some me bers of the cytochrome P450 family, whic is
composed of sev ral gen s [24], is regulated by DNA methylation [25].
, l t a -i t
of three carbazoles, PK083, PK9320, and PK9 23, in human bre st
adenocarcinoma cells (MCF-7) to ev luate their po ential u e s “anticancer (epi)drugs”
in a combinatorial mo ecular therapy [26], in additi n to th ir reported action as Y220C
mutant p53 reactivators [ 5,16].
e have c ose t i esti t t t i t f t t r l l , ti-
t ti el lit ti el , by perfor i the histone γ 2 phosphorylati assa an
t e o et assa . si t ese t o co le e tar tec i es e a le s to loo at t o
facets of the sa e kind of da age: fro the olecular point of vie and fro the
cellular one. In fact, the extent of 2 X phosphorylation correlates ith the nu ber of
regions ith DNA DSB, which are involved in the recruitment of DNA repair factors; at the
chromatin level, a DNA damage site, even in a transformed cell and within certain limits,
can still be repaired and its effect be silenced or underestimated. Also for this reason, this
assay was called “a surrogate marker” of DSB study [27]. In contrast, the alkaline Comet
assay, a useful technique for detecting the cyto-electrophoretic migration of nuclear DNA
with single- and double-strand breaks, visually and quantitatively shows DNA damage
at the cellular/nuclear level originating from several sources, even in the long term [28],
providing an overall picture of an entire population of cells “sensitively and precisely”,
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as was more recently reported [29]. Hence, both points of view were considered to better
characterize the genotoxic potency and to hypothesize more precisely on the mechanism of
action of the inducing molecules.
An innovative feature of this study is its epigenomic aspect. The in vitro/in vivo
study of the epigenetic effects of carbazole derivatives is a relatively new field, and only a
few publications have addressed this topic to date (A PubMed search in February 2021,
with “carbazole derivative epigenetic” as key words retrieved only 14 hits). Given that the
modulation of genomic DNA methylation is one of the crucial epigenetic modifications in
the oncogenic process and a biomarker implicated in various human pathologies, including
cancer [30], we also wanted to evaluate the capacity of the three molecules to act as
epigenomic modulators.
Taking the obtained results and the literature data into consideration, the findings
reported here allow us to make the following comments:
(1) First of all, it must be highlighted that the Comet assay performed on 5-azaC-
treated cells showed that there was no direct link between 5-azaC-induced genomic DNA
demethylation and DNA strand breaks. Therefore, these two toxicological endpoints can
be considered to be independent of one another.
(2) Our data showed significantly different genotoxic and epigenotoxic effects of
the tested molecules, with PK9323 being the most active in inducing molecular modifi-
cations. In fact, all the biological and epigenetic endpoints, at both the molecular and
nuclear/cellular level, clearly showed that this specific carbazole derivative possesses
a high (epi)genotoxic potency, as demonstrated by the highly significant differences in
the γH2AX phosphorylation, cell viability, Comet and MeSAP-PCR assays relative to the
control and the other tested carbazoles. This is the first description of the genotoxicity of
this newly synthesized molecule and, more generally, the first description of combined
effects, both genomic and epigenomic, of a carbazole derivative.
(3) Compound PK9320 might be labeled as genotoxically inactive, given that it was
not found to affect the level of histone phosphorylation; however, it is noteworthy that
it caused a drastic decrease in tubulin levels, indicative of cell death or inhibition of cell
growth. This result prompted us to examine the toxicity of this specific molecule from
different angles by probing its endocellular/endonuclear and epigenetic action, because
carbazole derivatives have been reported as non-toxic mainly when tested at the molecular
level, but highly genotoxic when submitted to other tests, including the Comet assay [12].
Consistent with these observations, we found that PK9320, at 10 µM concentration, was
able to reduce cell numbers in a highly significant way. Moreover, it was unable to cause
significant damage to nuclear DNA, as revealed by the Comet assay, at both 2.2 and
10 µM concentrations, but induced a statistically significant reduction of genomic DNA
methylation in both experimental conditions. PK9320, in summary, at the concentration
used in this study, appears to be a carbazole derivative endowed with a certain capability
to exert DNA damage, but mainly coming from its epigenomic modifying action at least
with regard to DNA methylation: an “epidrug” as defined by Ghasemi [31], which could
be better renamed as “pure epidrug”, given its specificity of action.
(4) Finally, PK083, a molecule structurally similar to PK9320 and PK9323, has shown
surprisingly attenuated, and in some cases even opposite, effects in almost all the analyses
performed in this study. In fact, this compound exerted a non-genotoxic effect when
assayed by phospho-γH2AX test and a protective effect on basal DNA damage, which
was highly significant at both administered concentrations with respect to the control.
Moreover, MeSAP-PCR data revealed that PK083 displayed a non-significant demethy-
lating potency on the CpG sites of genomic DNA, lower than that of 5-azaC. It may be
concluded that PK083 is a non-(epi)genotoxic molecule with a similar behavior to that
reported for ellipticine [32], a molecule with a tumor cell growth inhibitory ability, judged
as non-genotoxic by γH2AX assay. In our experimental system, the sole activity performed
by PK083 that can be considered toxic was the reduction of MCF-7 cell number when
administered at 10 µM concentration.
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Although there are still several unanswered questions that our study did not address,
such as the effect of carbazoles on histone acetylation/deacetylation balances, miRNA
variations and DNA methylation at the gene level, overall our data show that small
modifications in the substitution patterns of carbazoles can have profound effects on their
intrinsic genotoxic and epigenetic properties, which may be exploited for their use as
anticancer agents and probe molecules.
4. Materials and Methods
4.1. Cell Culture and Treatments
The MCF-7 breast tumor cell line was cultured in high glucose–DMEM medium
plus 10% foetal calf serum (FCS; ThermoFisher, Waltham, MA, USA), 100 U/mL peni-
cillin, 100 µg/mL streptomycin, and 2.5 mg/L amphotericin B (Invitrogen, Carlsbad, CA,
USA), at 37 ◦C in a 5% CO2 atmosphere. The cells were detached from flasks with 0.05%
trypsin-EDTA (Invitrogen), counted, and plated at the necessary density for treatment after
achieving 60−80% confluency. PK083, PK9320 and PK9323 were synthesized as reported by
Bauer et al. [15], dissolved in dimethyl sulfoxide (DMSO) firstly at 330 and 1500 mM stock
concentrations and then in 0.33 and 0.15 mM work concentrations, aliquoted in several
tubes to avoid freezing–thawing cycles and stored at −20 ◦C. The biological assays were
carried out for 20 h in the presence of the respective compound at the concentrations indi-
cated in the specific paragraphs; the working concentrations were obtained by dilution of
either stock solution with a constant volume of DMSO. Negative controls were prepared by
exposing cells to the same volume of DMSO vehicle only for 20 h. No significant difference
between untreated cells and DMSO-treated ones was found in relation to each biological
endpoint investigated. As a positive control for the epigenomic studies, cells were treated
with a 10 µM concentration of the DNA methyltransferase inhibitor 5-azaC for 48 h [25].
4.2. Morphological Observations and Cell Number Evaluation
MCF-7 cells were plated at a density of 1.0 × 106 cells/mL in 60-mm Petri dishes,
cultured in control conditions or in the presence of either PK083, PK9320 or PK9323 and
observed under an inverted OPTIKA phase-contrast microscope (Ponteranica, Italy) at the
end of the treatment. At least 50 microscopic fields were examined in three independent
experiments. Cell numbers were measured by direct counting in a Bürker chamber after
trypsinization [33].
4.3. DNA Damage Assays
4.3.1. Western Blot for Phospho-γH2AX Histone
MCF-7 breast cancer cells were seeded at a density of 1.0 × 105 cells/well in a 12-well
plate and allowed to settle for 48 h before exposure to PK083, PK9320, or DMSO. At the end
of the treatments, the cells were washed with phosphate-buffered saline and lysed using
1x SDS-loading buffer containing β-mercaptoethanol (5x buffer: 0.25% w/v bromophenol
blue, 0.5 M DTT (dithiothreitol), 50% v/v glycerol, 10% v/v SDS (sodium dodecyl sulphate)
and 0.25M Tris-HCl, pH 6.8). The lysates were sonicated and clarified by centrifugation at
13,000 r.p.m. before being loaded into 12% SDS-polyacrylamide gels. Proteins were sepa-
rated by SDS-PAGE at 200 V for 35 min. Western blot analysis of phospho-γH2AX histone
and the loading control α-tubulin was accomplished through transfer of protein onto PVDF
membranes using the Trans-Blot Turbo System (Bio-Rad, Hercules, CA, USA). Mouse mon-
oclonal anti-α-tubulin (DM1A) was purchased from Abcam (Cambridge, UK) and mouse
anti-phospho-histone H2AX (Ser139) (JBW301) was purchased from Millipore (Darmstadt,
Germany). Secondary antibodies were HRP-conjugated, polyclonal goat-derived antibod-
ies against mouse and rabbit (Dako, Agilent Technologies, Santa Clara, CA, USA). After
blotting and immunoreactions, protein bands were detected with a chemiluminescent
Western blotting substrate (SuperSignal West Femto, ThermoFisher) and the ImageQuant
LAS 4000 system (GE Healthcare, Chicago, IL, USA). Protein bands were quantified by
densitometry using ImageJ 1.50C and phospho-histone H2AX bands were normalized
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to the α-tubulin control band. DNA damage was reported as the percent of normalized
phospho-histone H2AX. DNA damage assays were repeated in triplicate and the half
maximal effective concentration (EC50) value for PK9323 compound compared with that of
cisplatin as a reference DNA lesion-inducing drug using the non-linear regression module
of Prism 6.0 (GraphPad, San Diego, CA, USA). In light of the results obtained from the
dose–response assays with PK9323, the following experiments were carried out for 20 h
in the presence of either 2.2 (PK9323 EC50) or 10 µM (maximum concentration tested) of
either of the three compounds; both working concentrations were obtained by dilution of
either stock solution with a constant volume of DMSO. Negative controls were prepared
by exposing cells to the same volume of DMSO vehicle only for 20 h.
4.3.2. Alkaline Comet Assay
The extent of the DNA damage in MCF-7 cells by PK083, PK9320 and PK9323 was
examined via single cell gel electrophoresis with the OxiSelect Comet assay kit (Cell Biolabs,
San Diego, CA, USA) as previously described [34,35]. Essentially, control and treated cells
were mechanically detached, resuspended at a density of 1.0 × 105/mL in Ca++/Mg++-free
phosphate-buffered saline and mixed with Comet agarose. The samples were then loaded
onto the OxiSelect Comet slides, allowed to gel, and treated with the lysis buffer followed
by an alkaline solution allowing DNA unwinding and denaturation. The damaged DNA
exhibiting both single- and double-strand breaks was separated from the intact fraction
through alkaline gel electrophoresis and, at the end of the run, the slides were fixed, air-
dried, and stained with Vista Green DNA or Gel red (Biotium, Fremont, CA, USA) Dye.
At least 50 nuclei were selected randomly per experiment, observed and photographed
under a Nikon Microphot SA fluorescence microscope and the olive tail moment (OTM)
was evaluated with the CASP Version 1.2.3b1 software (Sourceforge, Diceholdings Inc.,
New York, NY, USA).
4.4. DNA Extraction and Methylation-Sensitive Arbitrarily Primed Polymerase Chain Reaction
(MeSAP PCR)
Extraction of the genomic DNA of control and treated MCF-7 cells was performed
using the PureLink Genomic DNA Kit (Invitrogen) according to the manufacturer’s in-
structions, and the extracted DNA was quantitated using a NanoDrop® ND-1000 spec-
trophotometer (ThermoFisher), as previously described [36].
In order to evaluate the modulatory effects of PK083, PK9320 and PK9323 on the
genome-wide DNA methylation level, MeSAP-PCR experiments were carried out as previ-
ously reported [37,38]. Essentially, single-digested DNA (SDD) samples were obtained by
treating the genomic DNA with AfaI restriction endonuclease (ThermoFisher) whose cleav-
age site is (GT*AC). Subsequently, in order to obtain double-digested DNA (DDD), samples
aliquots of SDD were further treated with the methylation-sensitive HpaII restriction en-
donuclease (ThermoFisher), ineffective in cleaving the DNA when its recognition site
(CG*GG) contains a methylated cytosine. An arbitrarily primed two-step PCR experiment
was performed to amplify both SDD and DDD samples. The first PCR step (cycle profile:
94 ◦C for 5 min, four cycles at 94 ◦C for 30 s, 40 ◦C for 60 s and 72 ◦C for 90 s) was carried
out in the presence of a 21-mer arbitrary primer (5′-AACTGAAGCAGTGGCCTCGCG-3′)
in low stringency conditions, i.e., a permissive annealing temperature and a high salt and
primer concentration. This allows for the best matches between the arbitrary primer and
the genomic CpG sites, due to the complementary 3′ end of the former one. The second
highly stringent PCR step (cycle profile: 94 ◦C for 1 min, four cycles at 60 ◦C for 1 min and
72 ◦C for 2 min) was carried out in continuity, and, at the end, the amplified DNA was
separated through a non-denaturing 6% polyacrylamide gel electrophoresis, stained with
Gel Red nucleic acid gel stain (Biotium, Hayward, CA, USA), and analyzed with SigmaGel
v.1.0 image analysis software (SPSS, Chicago, IL, USA).
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4.5. Pharmacokinetic (PK) Studies
PK studies were carried out as outlined previously [39,40]. A detailed description of
the protocols can be found in the supporting information file.
4.6. Statistics
Data are presented as mean ± SEM (SD in Figure 3) from three independent experi-
ments. A Student’s t test was used and p < 0.05 was taken as the minimum level of statistical
significance between treated and control samples. The IQR values were calculated and
represented as a black line in the histograms.
5. Conclusions
In conclusion, we have studied the genotoxic and epigenotoxic properties of three
carbazole-derived molecules and demonstrated that, despite their similar structure, they
have very different biological activities, in particular towards the DNA molecule as a target.
The physicochemical properties of this carbazole series warrant some comments. In
the mass spectra of these analogues, we sometimes observed species with a reduced mass
that would be consistent with the loss of the amine side group and the formation of a
reactive iminium-methide species (Scheme 1; [15,41]). Given that the NHMe group is an
important interacting moiety for carbazoles in the p53-Y220C cavity (it forms an H-bond
with a D228 backbone carbonyl group as reported by [41]), such a reduction of binding
affinity would reduce their mutant p53 reactivation potential and possibly lead to off-target
effects. This aspect may be considered when designing the next generation of carbazole-
based Y220C mutant stabilizers to incorporate an interacting moiety that cannot result
in an elimination reaction, for example, by introducing an additional methylene group
between the carbazole ring and the amine group. However, so far there is no evidence that
this elimination occurs in cells.
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Apart fr m expanding the bi logical knowledge of the effects of specific carbazoles
on cellular genome status, the mol cular aspects pu in evidence in our study may provide
promisi g targ ts for ant -canc r herapeutic int rventions. I p rspective, we can define
these molecules, and PK9320 and PK9323 to a greater extent, as pharmacologically active
s bstances and, al hough further inv tigation w ll e necessary, as eligible candidates for
“antican er drugs” and “anticancer epi-drugs” on human breast adenocarcinoma cells. In
particular, t e lower dose of both molecules used in ur experiment l conditions appears to
be the most promising, because the higher dose could be so g notoxic to operate a danger-
ous clonal selection toward the development of clones more able to repair DNA breakages
and thus more aggressive. In addition, the property of the PK083 molecule, which accord-
ing to our data is even corrective of the basal DNA damage, will be worth investigating,
thereby opening new potential scenarios for its future biomedical applications.
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of genomic demethylation; Protocols for PK studies; Table S2: Results from PK studies.
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Machala, M.; et al. Genotoxicity of 7H-dibenzo[c,g]carbazole and its methyl derivatives in human keratinocytes. Mutat. Res.
Genet. Toxicol. Environ. Mutagen. 2012, 743, 91–98. [CrossRef] [PubMed]
12. Zhanataev, A.K.; Eremina, N.V.; Chayka, Z.V.; Kazey, V.I.; Andrianova, E.L.; Purmal, A.A.; Rydkina, E.B.; Durnev, A.D.
Genotoxicity of two new carbazole derivatives with antifungal activity. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2017,
816–817, 24–31. [CrossRef] [PubMed]
13. Joerger, A.C.; Fersht, A.R. The p53 pathway: Origins, inactivation in cancer, and emerging therapeutic approaches. Annu. Rev.
Biochem. 2016, 85, 375–404. [CrossRef]
14. Boeckler, F.M.; Joerger, A.C.; Jaggi, G.; Rutherford, T.J.; Veprintsev, D.B.; Fersht, A.R. Targeted rescue of a destabilized mutant of
p53 by an in silico screened drug. Proc. Natl. Acad. Sci. USA 2008, 105, 10360–10365. [CrossRef]
Int. J. Mol. Sci. 2021, 22, 3410 13 of 14
15. Bauer, M.R.; Jones, R.N.; Tareque, R.K.; Springett, B.; Dingler, F.A.; Verduci, L.; Patel, K.J.; Fersht, A.R.; Joerger, A.C.; Spencer, J. A
structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C. Future
Med. Chem. 2019, 11, 2491–2504. [CrossRef] [PubMed]
16. Bauer, M.R.; Krämer, A.; Settanni, G.; Jones, R.N.; Ni, X.; Khan Tareque, R.; Fersht, A.R.; Spencer, J.; Joerger, A.C. Targeting
cavity-creating p53 cancer mutations with small-molecule stabilizers: The Y220X paradigm. ACS Chem. Biol. 2020, 15, 657–668.
[CrossRef]
17. Sharma, A.; Singh, K.; Almasan, A. Histone H2AX phosphorylation: A marker for DNA damage. Methods Mol. Biol. 2012, 920,
613–626. [CrossRef]
18. Plappert-Helbig, U.; Libertini, S.; Frieauff, W.; Theil, D.; Martus, H.J. Gamma-H2AX immunofluorescence for the detection of
tissue-specific genotoxicity in vivo. Environ. Mol. Mutagen. 2019, 60, 4–16. [CrossRef]
19. Ceramella, J.; Iacopetta, D.; Barbarossa, A.; Caruso, A.; Grande, F.; Bonomo, M.G.; Mariconda, A.; Longo, P.; Carmela, S.; Sinicropi,
M.S. Carbazole derivatives as kinase-targeting inhibitors for cancer treatment. Mini-Rev. Med. Chem. 2020, 20, 444–465. [CrossRef]
[PubMed]
20. Sciandrello, G.; Mauro, M.; Caradonna, F.; Catanzaro, I.; Saverini, M.; Barbata, G. Acrylamide catalytically inhibits topoisomerase
II in V79 cells. Toxicol. Vitro 2010, 24, 830–834. [CrossRef]
21. Caradonna, F.; Mauro, M. Role of the antioxidant defence system and telomerase in arsenic-induced genomic instability.
Mutagenesis 2016, 31, 661–667. [CrossRef]
22. Griffiths, E.A.; Carraway, H.E.; Chandhok, N.S.; Prebet, T. Advances in non-intensive chemotherapy treatment options for adults
diagnosed with acute myeloid leukemia. Leuk. Res. 2020, 91, 106339. [CrossRef] [PubMed]
23. Gabelova, A. 7H-Dibenzo[c,g]carbazole: Metabolic pathways and toxicity. Chem. Biol. Interact. 2020, 323, 109077. [CrossRef]
[PubMed]
24. Catanzaro, I.; Naselli, F.; Saverini, M.; Giacalone, A.; Montalto, G.; Caradonna, F. Cytochrome P450 2E1 variable number tandem
repeat polymorphisms and health risks: A genotype-phenotype study in cancers associated with drinking and/or smoking. Mol.
Med. Rep. 2012, 6, 416–420. [CrossRef]
25. Naselli, F.; Catanzaro, I.; Bellavia, D.; Perez, A.; Sposito, L.; Caradonna, F. Role and importance of polymorphisms with respect to
DNA methylation for the expression of CYP2E1 enzyme. Gene 2014, 536, 29–39. [CrossRef]
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